Thus, the paradox in hepatic insulin resistance is that insulin fails to suppress hepatic glucose production, nevertheless it continues to stimulate lipogenesis, causing hyperglycemia, hyperlipidemia, hepatic steatosis, and T2DM [47]. The gene discussed is INS; the disease is Insulin resistance.